The Clorox Company (NYSE:CLX) Stock Holdings Lowered by Yousif Capital Management LLC

Yousif Capital Management LLC trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 61,549 shares of the company’s stock after selling 1,829 shares during the period. Yousif Capital Management LLC’s holdings in Clorox were worth $8,776,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. abrdn plc grew its holdings in shares of Clorox by 20.1% in the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after acquiring an additional 33,135 shares during the last quarter. International Assets Investment Management LLC increased its stake in Clorox by 17,658.5% in the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after purchasing an additional 481,725 shares in the last quarter. Adage Capital Partners GP L.L.C. purchased a new position in Clorox in the 3rd quarter worth about $6,605,000. Eagle Rock Investment Company LLC acquired a new stake in Clorox during the 4th quarter worth about $2,940,000. Finally, Nordea Investment Management AB raised its holdings in Clorox by 4.0% during the 4th quarter. Nordea Investment Management AB now owns 9,551 shares of the company’s stock worth $1,362,000 after buying an additional 364 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $147.79 on Thursday. The company’s fifty day moving average is $149.59 and its 200-day moving average is $142.27. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $178.21. The firm has a market cap of $18.34 billion, a price-to-earnings ratio of 234.59, a price-to-earnings-growth ratio of 2.31 and a beta of 0.43. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $1.08 by $1.08. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The business’s quarterly revenue was up 16.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.98 earnings per share. Equities analysts expect that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.25%. Clorox’s dividend payout ratio (DPR) is presently 761.92%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CLX. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a report on Thursday, January 18th. Citigroup cut their target price on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 16th. Barclays cut their target price on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research note on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft dropped their price target on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. Finally, The Goldman Sachs Group started coverage on Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 target price on the stock. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $148.63.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.